
Wall Street Journal - April 14, 2005
Marilyn Chase, marilyn.chase@wsj.com
The shield is an enzyme called A3G (short for APOBEC3G). A small version of this enzyme repels the virus. But when the A3G transforms into a large molecule, the shield becomes porous, letting HIV infect cells. If scientists can find a drug that preserves the small form of the enzyme, it could keep this antiviral shield intact and foil HIV , researchers said in the journal Nature.
"However it's working, it (A3G) knocks this virus flat," said Warner C. Greene, director of the Gladstone Institute of Virology and Immunology at the University of California at San Francisco. Postdoctoral fellow Ya-Lin Chiu was the lead researcher and Dr. Greene senior author of the study.
Ever since the discovery of HIV , scientists have grappled with the paradox that the virus can only infect key cells of the immune system, called T4-cells, when they are activated and trying to defend against invaders. T4-cells in a resting state, before activation, are impervious to HIV .
But A3G's defense can be undone when it grows into the larger A3G molecule.
050414
WJ050404
Copyright © 2005 - The Wall Street Journal. Reproduction of this article (other than one copy for personal reference) must be cleared through the WSJ Permissions Desk.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2005. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2005. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .